Hims & Hers (HIMS) grants director Christopher Payne 8,223 and 545 RSUs

Q: What equity awards did HIMS director Christopher D. Payne receive on this Form 4?

Christopher D. Payne received two Restricted Stock Unit grants: one for 8,223 RSUs and another for 545 RSUs , each representing a contingent right to receive one share of Class A Common Stock per RSU, subject to vesting.

Q: How do the new RSUs for HIMS director Christopher D. Payne vest?

The 8,223 RSUs vest in full on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date. The 545 RSUs vest in full on the company’s next quarterly vesting date.

Q: What is the value basis of the 545 RSUs granted to HIMS director Christopher D. Payne?

The 545 RSUs were issued in lieu of a director retainer fee of $16,598 . The number of units was calculated using a grant price of $30.40 per share under the company’s Director Compensation Policy.

Q: Are the RSUs reported by HIMS for Christopher D. Payne market purchases or compensation grants?

The transactions are compensation grants , not market purchases. Both entries use transaction code A , described as a grant, award, or other acquisition of RSUs under the company’s compensation arrangements for directors.

Q: What does each RSU reported by HIMS for Christopher D. Payne represent?

Each RSU represents a contingent right to receive one share of Class A Common Stock. Shares are delivered only upon satisfaction of the applicable vesting conditions and continued service requirements set out in the award terms.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Payne Christopher D reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. director Christopher D. Payne reported two equity compensation awards in the form of Restricted Stock Units (RSUs) linked to Class A Common Stock. He received 8,223 RSUs that, subject to continuous service, will vest on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date. He also received 545 RSUs issued under the Director Compensation Policy in lieu of a second-quarter 2026 cash retainer, calculated by dividing $16,598 of foregone fees by a $30.40 grant price; these RSUs will vest on the company’s next quarterly vesting date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Payne Christopher D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit ^{F1, F2}	8,223	$0.00	$0.00
Grant/Award	Restricted Stock Unit ^{F1, F3}	545	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 8,768 shares (Direct)

Footnotes (3)

F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.
F3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

Primary RSU grant: 8,223 RSUs Retainer RSU grant: 545 RSUs Foregone cash fees: $16,598 +1 more

4 metrics

Primary RSU grant 8,223 RSUs RSUs representing Class A Common Stock granted to Christopher D. Payne

Retainer RSU grant 545 RSUs RSUs issued in lieu of second-quarter 2026 director retainer fee

Foregone cash fees $16,598 Director retainer fee converted into 545 RSUs under Director Compensation Policy

Grant price basis $30.40 Price per share used to calculate 545 RSUs from $16,598 of fees

Key Terms

Restricted Stock Units, Director Compensation Policy, continuous service, vesting date

4 terms

Restricted Stock Units financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy"

continuous service financial

"Subject to continuous service, the RSUs will vest in full on the first Company quarterly"

vesting date financial

"will vest in full on the first Company quarterly vesting date to occur after the earlier"

FAQ

What equity awards did HIMS director Christopher D. Payne receive on this Form 4?

Christopher D. Payne received two Restricted Stock Unit grants: one for 8,223 RSUs and another for 545 RSUs, each representing a contingent right to receive one share of Class A Common Stock per RSU, subject to vesting.

How do the new RSUs for HIMS director Christopher D. Payne vest?

The 8,223 RSUs vest in full on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date. The 545 RSUs vest in full on the company’s next quarterly vesting date.

What is the value basis of the 545 RSUs granted to HIMS director Christopher D. Payne?

The 545 RSUs were issued in lieu of a director retainer fee of $16,598. The number of units was calculated using a grant price of $30.40 per share under the company’s Director Compensation Policy.

Are the RSUs reported by HIMS for Christopher D. Payne market purchases or compensation grants?

The transactions are compensation grants, not market purchases. Both entries use transaction code A, described as a grant, award, or other acquisition of RSUs under the company’s compensation arrangements for directors.

What does each RSU reported by HIMS for Christopher D. Payne represent?

Each RSU represents a contingent right to receive one share of Class A Common Stock. Shares are delivered only upon satisfaction of the applicable vesting conditions and continued service requirements set out in the award terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 04:23 PM Accepted by SEC EDGAR 08/14/2026 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Payne Christopher D

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

CALIFORNIA

94123

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	08/12/2026		A		8,223		⁽²⁾	⁽²⁾	Class A Common Stock	8,223	$0	8,223	D
Restricted Stock Unit	⁽¹⁾	08/12/2026		A		545		⁽³⁾	⁽³⁾	Class A Common Stock	545	$0	545	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR